| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.600 | 5.898 | 3.321 | 3.836 | 2.579 | 1.069 | 6.011 | 4.670 | 4.275 | 6.916 |
| Total Income - EUR | 3.600 | 5.898 | 3.321 | 3.836 | 2.579 | 1.069 | 6.012 | 4.779 | 4.619 | 7.254 |
| Total Expenses - EUR | 5.016 | 9.487 | 6.180 | 6.535 | 4.127 | 3.782 | 4.985 | 4.282 | 5.074 | 4.575 |
| Gross Profit/Loss - EUR | -1.417 | -3.590 | -2.859 | -2.698 | -1.548 | -2.714 | 1.028 | 497 | -455 | 2.680 |
| Net Profit/Loss - EUR | -1.525 | -3.767 | -2.959 | -2.813 | -1.625 | -2.731 | 1.013 | 354 | -455 | 2.289 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Krasmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.416 | 9.214 | 7.745 | 6.386 | 5.070 | 3.804 | 2.575 | 1.435 | 286 | 0 |
| Current Assets | 3.938 | 3.862 | 3.788 | 3.761 | 3.983 | 3.705 | 7.073 | 9.438 | 9.556 | 9.524 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.892 | 3.852 | 3.787 | 3.761 | 3.646 | 3.535 | 3.457 | 3.468 | 3.473 | 0 |
| Cash | 46 | 10 | 1 | 0 | 338 | 170 | 3.616 | 5.971 | 6.083 | 9.524 |
| Shareholders Funds | -4.909 | -8.626 | -11.438 | -14.042 | -15.395 | -17.834 | -16.426 | -16.123 | -16.530 | -14.149 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 19.263 | 21.702 | 22.972 | 24.189 | 24.449 | 25.342 | 26.074 | 26.996 | 26.372 | 23.673 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Krasmed Srl